Last Modified: April 6, 2005
Conference Dates: June 23-24, 2005
Conference Location: Courtyard Magnificent Mile Marriott, 165 East Ontario, Chicago, IL
Sponsoring Group: Northwestern University's Feinberg School of Medicine and the Multiple Myeloma Research Foundation
Conference Web Page URL: www.multiplemyeloma.org/medical_programs
Who Should Attend: June 23: Patients; June 24: Hematologists, Medical Oncologists, Oncology Nurses, Internists with Newly Diagnosed Patients
Registration Information: June 23 Patient Program: Contact the MMRF at 203-972-1250 or visit www.mulitplemyeloma.org/medical_programs. June 24 Professional Programs: contact Denise Marshall at (312)695-1392.
Conference Fees: June 23 patient program: Free; June 24 professional program: $50 registration fee
Continuing Education: Yes. 3.75 Category 1 credits available for physicians
Mar 1, 2015 - In patients with relapsed or resistant multiple myeloma who have received up to three prior therapies excluding the first-generation proteasome inhibitor bortezomib, treatment with the second-generation proteasome inhibitor carfilzomib is associated a high response rate and a low incidence of side effects, according to research presented at the annual meeting of the American Society of Hematology, held from Dec. 5 to 8 in New Orleans.
Mar 1, 2015
Dec 13, 2010